FDA Orange Book

Is there a generic for Winlevi?

Winlevi contains clascoterone. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

No. The Orange Book lists no active FDA-approved generic (ANDA) for Winlevi (clascoterone). The Orange Book shows its last listed patent expires August 26, 2031.

Run it in Rivvi

Map Winlevi and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Winlevi products in the Orange Book

Winlevi products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
cream, topical1%Marketed (Rx)None0None

NDA 213433, held by SUN PHARMACEUTICAL INDUSTRIES LTD. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Winlevi patents

Patents listed for Winlevi
PatentExpiresCoversUse codeNDA
12337002July 24, 2028Drug productU-3280213433
9486458July 24, 2028Method of useU-2942213433
11938141July 24, 2028Drug productNone213433
10159682August 14, 2028Method of useU-2942213433
11207332November 20, 2028Drug productU-3280213433
8785427July 25, 2030Drug productNone213433
9433628August 26, 2031Drug substance, Drug productNone213433

Winlevi NDC codes

Questions

Is there a generic for Winlevi?

No. The Orange Book lists no active FDA-approved generic (ANDA) for Winlevi (clascoterone). The Orange Book shows its last listed patent expires August 26, 2031.

What is the generic name for Winlevi?

The active ingredient in Winlevi is clascoterone, per the FDA Orange Book.

When does the Winlevi patent expire?

The last patent listed for Winlevi in the Orange Book expires August 26, 2031. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Winlevi and Clascoterone

Try it on your own data today.

Free to start. Most teams are using it the same day.